Please replace the release with the following corrected version due to a correction in the live presentation time.The updated release...
KELOWNA, BC / ACCESSWIRE / April 26, 2022 / Avant Brands Inc. (TSX:AVNT) (OTCQX:AVTBF) (FRA:1BU0) ("Avant" or the "Company"), a...
SALT LAKE CITY, UT, April 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – In the first calendar quarter (1Q) of...
AUSTIN, Tex., April 26, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company, today announced it will...
CAMBRIDGE, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that the...
Seamless, Comprehensive Capabilities Eliminate Barriers to Microbiome ResearchRENSSELAER, N.Y., April 26, 2022 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader...
Company continues innovating preclinical tools used in new and ongoing small animal research and product development with SmartStudy™ SmartStudy Technology...
Tampa, April 26, 2022 (GLOBE NEWSWIRE) -- Alcohol Awareness Month began in 1987 and was formerly funded through the National...
Four ARVO presentations accepted will feature data from APX3330 Phase 2b trial in Diabetic Retinopathy and Nyxol® Phase 2 trial...
Gold Award Recognizes Antibody TestRARITAN, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (NASDAQ: OCDX), one of the world's...
Minerva calls on women to talk about their periodsSANTA CLARA, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc....
DUBLIN, Ireland and BRIDGEWATER, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) announced today its partner HLS...
DURHAM, N.C., April 26, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in...
GB0139 is Galecto’s proprietary inhaled once-daily small molecule galectin-3 inhibitor GALACTIC-1 trial on track to deliver top-line results in mid-2023...
Senior Director of Marketing Theresa Ferguson selected as marketing lead for Predictive OncologyEAGAN, Minn., April 26, 2022 (GLOBE NEWSWIRE) --...
DENVER, April 26, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative...
Conference Call on Tuesday, May 10, 2022 at 8:30 a.m. ETLEXINGTON, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Agenus (NASDAQ:...
FREMONT, CA, April 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
PRX012 is a potential best-in-class, subcutaneous anti-amyloid beta antibody therapy currently in a Phase 1 clinical study for the treatment...
BASEL, Switzerland, April 26, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) today announced it will host a webcast and conference...
